Unseen Burden: Alarming Waste in Clinical Trial Data Collection Revealed

Clinical trials, vital for medical breakthroughs, are plagued by a significant inefficiency: nearly 30% of painstakingly collected data remains unused. This 'unseen burden' represents a substantial financial drain on the pharmaceutical and biotechnology industries and raises profound ethical questions regarding patient participation. The article highlights that this data waste not only erodes resources but also burdens patients, calling for urgent introspection and a more streamlined, patient-centric approach to clinical research to address this silent inefficiency.